Selected research
Industry Research
Tablet Pharmaceutical Excipients Industry Research Report 2026
Market perspective
The global Tablet Pharmaceutical Excipients market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tablet Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tablet Pharmaceutical Excipients is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tablet Pharmaceutical Excipients is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tablet Pharmaceutical Excipients include Merck, Lubrizol, Roquette, Protheragen-ING, Meggle-Pharma, Kerry Group, IFF Pharma Solutions, Gattefossé and DFE Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tablet Pharmaceutical Excipients market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tablet Pharmaceutical Excipients Market by Company
Merck
Lubrizol
Roquette
Protheragen-ING
Meggle-Pharma
Kerry Group
IFF Pharma Solutions
Gattefossé
DFE Pharma
Colorcon
BASF
Abitec
Tablet Pharmaceutical Excipients Segment by Type
Disintegrants
Lubricants
Binders
Colorants
Others
Tablet Pharmaceutical Excipients Segment by Application
Tablets for Oral Use
Tablets for External Use
Tablet Pharmaceutical Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tablet Pharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tablet Pharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tablet Pharmaceutical Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tablet Pharmaceutical Excipients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tablet Pharmaceutical Excipients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tablet Pharmaceutical Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Disintegrants
- Lubricants
- Binders
- Colorants
- Others
Applications
- Tablets for Oral Use
- Tablets for External Use
Companies covered
- Merck
- Lubrizol
- Roquette
- Protheragen-ING
- Meggle-Pharma
- Kerry Group
- IFF Pharma Solutions
- Gattefossé
- DFE Pharma
- Colorcon
- BASF
- Abitec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tablet Pharmaceutical Excipients Market Size (2021-2032)
- 2.2.2 Global Tablet Pharmaceutical Excipients Sales (2021-2032)
- 2.2.3 Global Tablet Pharmaceutical Excipients Market Average Price (2021-2032)
- 2.3 Tablet Pharmaceutical Excipients by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Disintegrants
- 2.3.3 Lubricants
- 2.3.4 Binders
- 2.3.5 Colorants
- 2.3.6 Others
- 2.4 Tablet Pharmaceutical Excipients by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablets for Oral Use
- 2.4.3 Tablets for External Use
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tablet Pharmaceutical Excipients Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tablet Pharmaceutical Excipients Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Tablet Pharmaceutical Excipients Revenue of Manufacturers (2021-2026)
- 3.4 Global Tablet Pharmaceutical Excipients Average Price by Manufacturers (2021-2026)
- 3.5 Global Tablet Pharmaceutical Excipients Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tablet Pharmaceutical Excipients, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tablet Pharmaceutical Excipients, Product Type & Application
- 3.8 Global Manufacturers of Tablet Pharmaceutical Excipients, Established Date
- 3.9 Global Tablet Pharmaceutical Excipients Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Tablet Pharmaceutical Excipients Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Lubrizol
- 4.2.1 Lubrizol Company Information
- 4.2.2 Lubrizol Business Overview
- 4.2.3 Lubrizol Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lubrizol Tablet Pharmaceutical Excipients Product Portfolio
- 4.2.5 Lubrizol Recent Developments
- 4.3 Roquette
- 4.3.1 Roquette Company Information
- 4.3.2 Roquette Business Overview
- 4.3.3 Roquette Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roquette Tablet Pharmaceutical Excipients Product Portfolio
- 4.3.5 Roquette Recent Developments
- 4.4 Protheragen-ING
- 4.4.1 Protheragen-ING Company Information
- 4.4.2 Protheragen-ING Business Overview
- 4.4.3 Protheragen-ING Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Protheragen-ING Tablet Pharmaceutical Excipients Product Portfolio
- 4.4.5 Protheragen-ING Recent Developments
- 4.5 Meggle-Pharma
- 4.5.1 Meggle-Pharma Company Information
- 4.5.2 Meggle-Pharma Business Overview
- 4.5.3 Meggle-Pharma Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Meggle-Pharma Tablet Pharmaceutical Excipients Product Portfolio
- 4.5.5 Meggle-Pharma Recent Developments
- 4.6 Kerry Group
- 4.6.1 Kerry Group Company Information
- 4.6.2 Kerry Group Business Overview
- 4.6.3 Kerry Group Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Kerry Group Tablet Pharmaceutical Excipients Product Portfolio
- 4.6.5 Kerry Group Recent Developments
- 4.7 IFF Pharma Solutions
- 4.7.1 IFF Pharma Solutions Company Information
- 4.7.2 IFF Pharma Solutions Business Overview
- 4.7.3 IFF Pharma Solutions Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 IFF Pharma Solutions Tablet Pharmaceutical Excipients Product Portfolio
- 4.7.5 IFF Pharma Solutions Recent Developments
- 4.8 Gattefossé
- 4.8.1 Gattefossé Company Information
- 4.8.2 Gattefossé Business Overview
- 4.8.3 Gattefossé Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gattefossé Tablet Pharmaceutical Excipients Product Portfolio
- 4.8.5 Gattefossé Recent Developments
- 4.9 DFE Pharma
- 4.9.1 DFE Pharma Company Information
- 4.9.2 DFE Pharma Business Overview
- 4.9.3 DFE Pharma Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 DFE Pharma Tablet Pharmaceutical Excipients Product Portfolio
- 4.9.5 DFE Pharma Recent Developments
- 4.10 Colorcon
- 4.10.1 Colorcon Company Information
- 4.10.2 Colorcon Business Overview
- 4.10.3 Colorcon Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Colorcon Tablet Pharmaceutical Excipients Product Portfolio
- 4.10.5 Colorcon Recent Developments
- 4.11 BASF
- 4.11.1 BASF Company Information
- 4.11.2 BASF Business Overview
- 4.11.3 BASF Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 BASF Tablet Pharmaceutical Excipients Product Portfolio
- 4.11.5 BASF Recent Developments
- 4.12 Abitec
- 4.12.1 Abitec Company Information
- 4.12.2 Abitec Business Overview
- 4.12.3 Abitec Tablet Pharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Abitec Tablet Pharmaceutical Excipients Product Portfolio
- 4.12.5 Abitec Recent Developments
5 Global Tablet Pharmaceutical Excipients Market Scenario by Region
- 5.1 Global Tablet Pharmaceutical Excipients Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tablet Pharmaceutical Excipients Sales by Region: 2021-2032
- 5.2.1 Global Tablet Pharmaceutical Excipients Sales by Region: 2021-2026
- 5.2.2 Global Tablet Pharmaceutical Excipients Sales by Region: 2027-2032
- 5.3 Global Tablet Pharmaceutical Excipients Revenue by Region: 2021-2032
- 5.3.1 Global Tablet Pharmaceutical Excipients Revenue by Region: 2021-2026
- 5.3.2 Global Tablet Pharmaceutical Excipients Revenue by Region: 2027-2032
- 5.4 North America Tablet Pharmaceutical Excipients Market Facts & Figures by Country
- 5.4.1 North America Tablet Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.4.3 North America Tablet Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Tablet Pharmaceutical Excipients Market Facts & Figures by Country
- 5.5.1 Europe Tablet Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.5.3 Europe Tablet Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Tablet Pharmaceutical Excipients Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tablet Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tablet Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tablet Pharmaceutical Excipients Market Facts & Figures by Country
- 5.7.1 South America Tablet Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.7.3 South America Tablet Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Tablet Pharmaceutical Excipients Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tablet Pharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tablet Pharmaceutical Excipients Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Tablet Pharmaceutical Excipients Sales by Type (2021-2032)
- 6.1.1 Global Tablet Pharmaceutical Excipients Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Tablet Pharmaceutical Excipients Sales Market Share by Type (2021-2032)
- 6.2 Global Tablet Pharmaceutical Excipients Revenue by Type (2021-2032)
- 6.2.1 Global Tablet Pharmaceutical Excipients Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tablet Pharmaceutical Excipients Revenue Market Share by Type (2021-2032)
- 6.3 Global Tablet Pharmaceutical Excipients Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tablet Pharmaceutical Excipients Sales by Application (2021-2032)
- 7.1.1 Global Tablet Pharmaceutical Excipients Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Tablet Pharmaceutical Excipients Sales Market Share by Application (2021-2032)
- 7.2 Global Tablet Pharmaceutical Excipients Revenue by Application (2021-2032)
- 7.2.1 Global Tablet Pharmaceutical Excipients Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tablet Pharmaceutical Excipients Revenue Market Share by Application (2021-2032)
- 7.3 Global Tablet Pharmaceutical Excipients Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tablet Pharmaceutical Excipients Value Chain Analysis
- 8.1.1 Tablet Pharmaceutical Excipients Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tablet Pharmaceutical Excipients Production Mode & Process
- 8.2 Tablet Pharmaceutical Excipients Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tablet Pharmaceutical Excipients Distributors
- 8.2.3 Tablet Pharmaceutical Excipients Customers
9 Global Tablet Pharmaceutical Excipients Analyzing Market Dynamics
- 9.1 Tablet Pharmaceutical Excipients Industry Trends
- 9.2 Tablet Pharmaceutical Excipients Industry Drivers
- 9.3 Tablet Pharmaceutical Excipients Industry Opportunities and Challenges
- 9.4 Tablet Pharmaceutical Excipients Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst